Inflammation plays a central role in pancreatic cancer etiology and can be modulated by diet. We aimed to examine the association between the inflammatory potential of diet, assessed with the Dietary Inflammatory Index (DIIV R ), and pancreatic cancer risk in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial prospective cohort. Our study included 101,449 participants aged 52-78 years at baseline who completed both baseline questionnaire and a diet history questionnaire. Energy-adjusted DII (E-DII) scores were computed based on food and supplement intake. Cox proportional hazards models and time dependent Cox models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) with participants in the lowest E-DII quintile (most anti-inflammatory scores) as referent. After a median 8.5 years of follow-up, 328 pancreatic cancer cases were identified. E-DII scores were not associated with pancreatic cancer risk in the multivariable model (HR Q5vsQ1 5 0.94; 95% CI 5 0.66-1.35; p-trend 5 0.43). Time significantly modified the association (p-interaction 5 0.01). During follow up <4 years, there was suggestive evidence of an inverse association between E-DII and pancreatic cancer (HR Q5vsQ1 5 0.60; 95% CI 5 0.35-1.02; p-trend 5 0.20) while there was a significant positive trend in the follow up 4 years (HR Q5vsQ1 5 1.31; 95% CI 5 0.83-2.08; p-trend 5 0.03). Similar results were observed for E-DII from food only. Our study does not support an association between inflammatory potential of diet and pancreatic cancer risk; however, heterogeneous results were obtained with different follow-up times. These divergent associations may result from the influences of undetected disease in the short-term.
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combined. 2 Although the etiology of pancreatic cancer is not fully understood, inflammation may play a pivotal role in the pathogenesis of this malignancy, largely because inflammatory states are etiologically linked to wellrecognized risk factors for pancreatic cancer, including chronic pancreatitis, cigarette smoking, obesity, and diabetes. 3, 4 Dietary factors could affect cancer risk through modulation of inflammation, 5 realized mainly by dietary impact on visceral obesity, 6 oxidative damage 7 and insulin resistance. 6 Therefore, understanding the effect of dietary inflammatory potential on the development of pancreatic cancer may guide dietary intervention strategies aimed at the primary prevention of this lethal malignancy. A number of epidemiological studies have reported inconsistent results regarding the relationship between pancreatic cancer risk and inflammationmodulating nutrients or foods, such as fruits and vegetables and associated vitamins, 8, 9 fat and fatty acids, 10 fiber, 11 whole grains 12 and flavonols. 13 A typical human diet consists of both proinflammatory and anti-inflammatory foods and nutrients. Therefore, a dietary pattern approach, which takes into account the complex interactions among dietary components, has advantages over individual foods or nutrients when being studied for associations with disease risk.
14 Assessing the overall inflammatory potential of the diet may provide better insight on the effect on pancreatic cancer risk than assessing only a select set of nutrients or individual foods. To date, two case-control studies have used the Dietary Inflammatory Index (DII V R ) to assess the association between dietary inflammatory potential and pancreatic cancer risk; both studies reported a significant more than twofold increased risk in the most proinflammatory diet group. 15, 16 However, case-control studies are susceptible to recall and selection biases, which may distort the true associations. 17 Therefore, a large prospective cohort study in which exposure information has been collected before the cancer diagnosis is advantageous for examining the role of diet in pancreatic cancer etiology. The objective of this study was to examine the association between inflammatory potential of diet, as estimated by the DII, and pancreatic cancer risk using data from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial prospective cohort.
Materials and Methods

Study design
The PLCO was a multicenter population-based randomized trial designed to assess effects of screening tests for prostate, lung, colorectal and ovarian cancers on mortality and secondary endpoints. Details of this study have been described elsewhere. 18 Briefly, between 1993 and 2001, a total of 154,897 eligible participants (76,682 men and 78,215 women), aged 55-74 years, were enrolled into the trial from 10 screening centers across the United States. Participants were randomized by sex and age group into a control arm, where usual medical care was received, or intervention arm where screening exams for PLCO cancers were received. PLCO eligibility criteria excluded a previous personal history of PLCO cancers, ongoing cancer treatment (excluding basal-cell and squamous-cell skin cancer), participation in another cancer screening or cancer primary prevention trial, and a recent screening test for prostate or colorectal cancer. 18 Participants in the intervention arm received their screening tests during their first six years in the trial and were subsequently followed up for at least seven additional years; participants in the control arm also were followed for 13 years after enrollment. 18 
Study population
In our analyses, we further excluded 11,874 participants who had a cancer (except non-melanoma skin cancer) diagnosed before completing the diet history questionnaire (DHQ); 4,920 participants who did not return baseline questionnaires; 36,268 participants who did not have valid DHQ responses (i.e., valid DHQ responses were defined as having DHQ completion date; alive at DHQ completion; <8 missing DHQ responses; and plausible caloric intake defined as within the sex-specific first and last percentiles of total energy); 220 participants who reported unreasonable body mass index (BMI) (i.e., BMI was considered unreasonable if one of the followings occurred: weight < 60 pounds; height <48 inches; height >78 inches for females; height >84 inches for males; BMI <15 kg/m 2 ) and 166 participants without follow-up data. After these exclusions, the analytical cohort included 101,449 participants (49,347 men and 52,102 women). The study was approved by the institutional review boards of the National Cancer Institute and each of the centers that participated. Informed consent was obtained from each eligible participant in the study.
What's new?
Inflammatory conditions including chronic pancreatitis and obesity are risk factors for pancreatic cancer, and diet can modulate inflammation. While the inflammatory potential of diet has previously been associated with pancreatic cancer in two case-control studies, possible recall and selection biases cannot be excluded. Here, the authors examined the association between the inflammatory potential of diet as assessed with the Dietary Inflammatory Index and pancreatic cancer risk in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial prospective cohort. No association was found between inflammatory potential of diet and pancreatic cancer risk; however, heterogeneous results were obtained with different follow-up times.
Dietary assessment
Diet was assessed by a self-reported food frequency questionnaire (FFQ), the DHQ version 1.0 (National Cancer Institute, 2007), which was introduced in 1998 to both control and intervention arms within a median of three years after randomization in the trial. 19 Energy-adjusted DII score calculation
The energy-adjusted DII (E-DII) score for each participant was calculated based on the reported nutrient and food intake from the DHQ with linkage to the corresponding inflammatory effect scores designated in the DII. 22 The DII is a literature-derived, population-based dietary index designed to estimate the overall inflammatory potential of an individual's diet. The details of the development of the DII have been published previously. 22 Briefly, 1,943 eligible peer-reviewed primary research articles published through 2010 on the effect of dietary factors on six inflammatory markers (interleukin (IL)-1b, IL-4, IL-6, IL-10, tumor necrosis factor-a (TNF-a) and C-reactive protein (CRP)) were identified and scored to derive the component-specific inflammatory effect scores for 45 dietary factors (i.e., components of DII), which comprised macronutrients, micronutrients and some foods or bioactive components such as spices and tea. 22 Ten DII components including ginger, turmeric, garlic, oregano, rosemary, eugenol, saffron, n-3 fatty acids, n-6 fatty acids and flavonols were not available from the DHQ. Therefore, the remaining 35 components were used for E-DII score calculation in our analysis. The food and nutrient consumption estimated from the DHQ was first multiplied by 1000 and divided by energy intake to account for the difference in individual energy intake. To avoid the arbitrariness as a result of simply using raw intake amounts, the energy-adjusted dietary intake was subsequently standardized to a composite dietary database representing energy-adjusted dietary intake from 11 populations living in different countries across the world for each DII component in the study. 22 The energyadjusted standardized dietary intake was then multiplied by the literature-derived inflammatory effect score for each DII component, and summed across all components to obtain the overall E-DII score. 22 Higher E-DII scores represent more proinflammatory diets while lower (i.e., more negative) E-DII scores indicate more anti-inflammatory diets. The DII score has been construct-validated and found to be associated with higher levels of inflammatory biomarkers including IL-6, 23 TNF-a receptor 2 23 and high-sensitivity CRP. 24 Because a majority of the participants (79%) in the PLCO consumed supplements, and most dietary factors used in supplements have anti-inflammatory properties, 25 we reported E-DII scores from food plus supplements and E-DII scores from food only as exposures to quantify the association between the inflammatory potential of diet, with and without supplements, in relation to pancreatic cancer risk.
Assessment of other covariates
Baseline characteristics-which included demographic information, personal medical history, family history and health behaviors-were self-reported through the baseline questionnaire within 3 months of randomization in the PLCO. BMI was calculated as weight (kg)/height(m) 2 and categorized based on the World Health Organization criteria. 26 Information on physical activity over the past year was not assessed at baseline, but was assessed on the supplemental questionnaire (SQX) which was introduced at a median of nine years after randomization in the trial.
Pancreatic cancer case ascertainment
Incident pancreatic cancer cases were identified through an annual study update questionnaire in which participants reported if they had been diagnosed with any cancer by a healthcare provider, the type of cancer, date of diagnosis, and location of diagnosis. State registries, death certificates and physician reports also were used as additional sources for identification of pancreatic cancer cases. All reports of pancreatic cancer were followed up and medical records were abstracted and reviewed for case ascertainment. In this analysis, pancreatic cancer case was defined as primary incident adenocarcinoma of the exocrine pancreas (International Classification of Diseases for Oncology, Third Edition, codes C25.0-C25.3, C25.7-C25.9). Our case definition excluded pancreatic endocrine tumors and other rare histology types of pancreatic cancer (histology type 8150, 8154, 8240,8245, 8246, 8550) as etiology may differ, 27 and we censored these types of pancreatic cancer at the date of diagnosis.
Statistical analysis
The baseline characteristics of the study population were presented by quintiles of E-DII from food plus supplements with cutoff points determined from the distribution of the entire cohort. Means and standard errors (SE) for continuous variables and frequencies and percentages for categorical variables were calculated. Participants were followed up from the date of DHQ completion to the date of diagnosis of pancreatic cancer, death from any cause, study withdrawal or the end date of study follow-up (the first of either 13 years after randomization or 12/31/2009), whichever came first. Cox proportional modeling, with person-year as the underlying time metric, was used to estimate the HRs and 95% confidence intervals (CIs) for higher E-DII quintiles compared to the lowest E-DII quintile (the most anti-inflammatory score) as referent. To test the linear trend of pancreatic cancer risk across E-DII score, a continuous E-DII variable was used. Variables were considered as confounders if they were associated with both pancreatic risk and E-DII (in either continuous or categorical format), or they changed the crude risk estimate by >10% in bivariate analyses. We also included BMI and educational attainment a priori in the model as previous research suggests they are related to both pancreatic cancer and dietary intake. [28] [29] [30] In the multivariable models, we adjusted for age at DHQ completion, sex (male or female), BMI (underweight, normal, overweight, obese, missing), educational attainment (high school or below, post high school training other than college, some college, college, postgraduate, missing), pack-year categories within smoking status (never smoker, former smoker with <18 pack-years, former smoker with 18-41 pack-years, former smoker with >41 pack-years, current smoker with <18 pack-years, current smoker with 18-41 pack-years, current smoker with >41 pack-years, missing), alcohol drinking (0, 0-3, >3 drinks/day), history of diabetes (yes, no, missing), and total energy intake (kcal/day). The proportional hazards (PH) assumption was examined using the Schoenfeld residual test. 31 There was no evidence that E-DII or any covariate violated the PH assumption.
Effect modification by sex, BMI, history of diabetes and smoking status were examined by adding the cross-product of each effect modifier with E-DII quintile in the multivariable-adjusted model with p values 0.10 as an indicator of significant effect modification. Given the possibility of latent pancreatic cancer affecting recent dietary intake, previous PLCO analyses suggested that time significantly modified the association between dietary fat and available carbohydrate and pancreatic cancer using a cutoff of 4 years of follow-up. 32, 33 We therefore examined if the E-DII and pancreatic cancer association differed in these two time periods using the multivariable-adjusted time-dependent COX model, with cutoff point at 4 years of follow-up, to be comparable with the other PLCO analyses. 32, 33 In sensitivity analyses, subjects who self-reported diabetes history at baseline were removed from analyses because diabetes may be a preclinical indicator of pancreatic cancer and diet modification may have occurred after diagnosis of diabetes. 34, 35 We also excluded alcohol abstainers, heavy alcohol users (>3 drinks/day), or both from the cohort to reassess all the aforementioned associations as alcohol has been reported to have a nonlinear association with pancreatic cancer. 29, 36 In addition, as we excluded a large number of participants, we compared the demographic characteristics and pancreatic cancer risk factors between our included sample and excluded subjects to examine how results could have been affected by excluding these subjects in our analyses.
Identical analyses, including sensitivity analyses, were performed for E-DII from food only in relation to pancreatic cancer risk. All statistical analyses were conducted using SAS V R (version 9.4, Cary, NC). All tests were two-sided, with p values <0.05 considered statistically significant unless otherwise noted.
Results
After a median of 8.5 years of follow-up, 328 incident pancreatic cancer cases occurred. E-DII scores from food and supplements ranged from 28.43 to 16.38. Compared to participants who had the most anti-inflammatory E-DII scores from food and supplement (i.e., E-DII quintile 1), participants consuming a more proinflammatory diet had higher BMI and smoked more heavily at baseline, were younger at the time of DHQ completion, consumed more alcohol, and were more likely to be male, Black non-Hispanic or Hispanic, current smokers, have below-college education level, have a probable family history of pancreatic cancer in a first-degree relative, and have a personal history of diabetes (Table 1) .
HRs for pancreatic cancer risk across E-DII quintiles from food plus supplement are presented in Table 2 . After controlling for confounders, there was no significant association between E-DII scores and pancreatic cancer risk (HR Q5vsQ1 5 0.94, 95% CI 5 0.66-1.35, p-trend 5 0.43). After excluding subjects with a history of diabetes at baseline (n 5 7,319), the multivariableadjusted HRs changed only slightly. After excluding alcohol abstainers, alcohol heavy users, and both, results were not substantially different (data not shown).
When stratifying by sex, BMI category, history of diabetes, smoking status and follow-up time (<4 and 4 person-years in the time dependent Cox models), the association between E-DII scores and pancreatic cancer risk only differed in the two person-year interval (p-interaction 5 0.01) ( Table 3) . During <4 years of follow-up, those consuming the most proinflammatory diets had a 40% lower risk of pancreatic cancer compared with individuals with the most anti-inflammatory diets but the trend was not significant (multivariable HR Q5vsQ1 5 0.60, 95% CI 5 0.35-1.02, ptrend 5 0.20). However, a significant positive trend was seen among individuals after 4 years, although the HR comparing two extreme quintiles was not statistically significant (multivariable HR Q5vsQ1 5 1.31, 95% CI 5 0.83-2.08, ptrend 5 0.03). We performed the same analysis in follow-up time <4 years and 4 years in the sensitivity analysis using the time dependent Cox model after excluding subjects with diabetes history, and the results did not change (data not shown). In the sensitivity analyses of excluding alcohol abstainers, alcohol heavy users, or both, we did not notice a material change of HR estimates in the two person-year interval, although the trend in the follow-up 4 years became nonsignificant and the modification of time effect 
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was not significant, likely due to the smaller sample size (data not shown).
Similar patterns of associations were observed when analyses were performed with E-DII from food only. In the multivariable analyses, E-DII from food only was not associated with pancreatic cancer risk (HR Q5vsQ1 Table 2 ). After excluding alcohol abstainers, alcohol heavy users, or both, results did not change substantially in the main association and association among two time intervals, but the time modification effect was attenuated and became nonsignificant (data not shown).
Compared to subjects included in analyses, excluded subjects tended to have less healthy behaviors or characteristics that are likely associated with increased risk of pancreatic cancer, including heavier smoking, a more proinflammatory diet, older age, diabetes history and lower education attainment. They also were more likely to be male and Blacks or Hispanics (Supporting Information, Table 3 ).
Discussion
This is the first prospective cohort study investigating the association between dietary quality with respect to inflammatory potential and pancreatic cancer risk. Overall, no association was found between inflammatory potential of diet and pancreatic cancer risk. However, the association between E-DII and pancreatic cancer significantly differed in the first 4 years versus in the follow-up longer than 4 years. We observed a significant increased trend of risk associated with a pro-inflammatory diet during follow-up longer than four years, whereas suggestive evidence of risk reduction was seen in the first four years of follow-up. These divergent associations may indicate the presence of reverse causality in the short term, where decreases in dietary inflammatory potential may be a consequence, rather than a cause, of pancreatic cancer or a well-known precursor condition, pancreatitis. 37 We observed similar results for E-DII from food plus supplements and E-DII from food only.
Two case-control studies, with one conducted in the US 16 and the other in Italy, 15 previously reported positive associations between E-DII scores from food and pancreatic cancer risk. Both studies found an 2.5-fold increased risk of pancreatic cancer in the highest compared to the lowest quintile of the E-DII group (U.S.: OR Q5vsQ1 5 2.54, 95% CI 5 1.87-3.46, p-trend < 0.0001; 16 Italy: OR Q5vsQ1 5 2.48, 95% CI 5 1.50-4.10, p-trend 5 0.002 15 ). Evidence of effect modification by smoking status and BMI was documented in the Italian case-control study, in which a significant positive association was observed among never and past smokers but not among current smokers, and among normal and overweight rather than obese subjects, respectively. 15 In the US case-control study using a joint effect approach, Antwi et al. demonstrated that dietary inflammatory potential may act synergistically with cigarette smoking and diabetes to increase the risk of pancreatic cancer beyond the risk of any of these factors alone. 16 Compared to these two case-control studies, a significant association was not observed in the PLCO and the magnitude of the association was much weaker, even after 4 years of follow-up where the effect of subjects who may have changed diet due to symptoms associated with latent pancreatic cancer in the early follow-up period was minimized. There are differences between the prospective cohort design we utilized and a case-control design which are important to note. Differential misclassification of exposure is minimized in a cohort design because exposure is measured before the outcome develops, but it is measured after the outcome has occurred in a case-control design, possibly resulting in differential recall. In addition, there may be biased selection of cases and controls in a case-control study which may induce selection bias and thus biased associations. 17 We did not observe evidence of effect modification in our study except for follow-up time which, as noted above, may reflect subclinical disease. Although many pancreatic cancer studies have performed lag time analysis by excluding subjects with short follow-up time to alleviate concerns about changes in diet driven by preclinical symptoms of pancreatic cancer (or precursor conditions, especially pancreatitis), few studies have examined time as an effect modifier with dietary exposure. Our study finding of heterogeneous associations between E-DII and pancreatic cancer with <4 years of follow up versus 4 years of follow-up were consistent with two previous analyses of diet and pancreatic cancer in the PLCO cohort, of which both found time was the only significant effect modifier. 32, 33 In the study by Arem et al., higher saturated fat intake (proinflammatory) was associated with significantly reduced pancreatic cancer risk among subjects with <4 years of follow-up, and associations became weaker and nonsignificant after excluding these subjects. 32 In the other PLCO study examining dietary glycemic load and available carbohydrates as well as total and saturated fat, the positive association of pancreatic cancer with glycemic load and available carbohydrate and inverse association with saturated fat were observed only in the first four years, but not subsequently. 33 Pancreatic cancer patients may present with severe, though nonspecific symptoms such as impaired glucose control, fatigue, jaundice, abdominal pain, nausea, blunted appetite and vomiting before actual diagnosis, which is usually at a late stage because there exists no accurate method for early detection. 38 Thus, assessment of dietary intake in pancreatic cancer studies, which typically query diet in the past 12 months, may capture disease-related diet changes (or those related to precursor conditions), rather than intake prior to cancer symptoms. 33 In our study, subjects may choose to eat healthier or more anti-inflammatory food or less amount of total food (i.e., fewer calories) due to symptoms associated with latent diseases in the early time period, which resulted in lower E-DII scores. Although prospective studies are less susceptible to reverse causation bias, such bias can occur in prospective studies of pancreatic cancer, given the cancer's 42 and dietary total antioxidant capacity score. 43 Results from these studies all suggested better diet quality was associated with lower pancreatic cancer risk, with effect estimates ranging from 0.44 39 to 0.92 40 comparing the highest with the lowest dietary quality group. However, our study suggested a nonsignificant association with total inflammation potential of diet. The different findings may be, to some extent, explained by the differences in dietary patterns under study, the nature of the FFQs, study design, study population, sample size, timing from dietary data collection to diagnosis or some combinations of these.
It is well-recognized that proinflammatory states foster a cellular environment that supports the development of genetic mutations and the initiation of pancreatic carcinogenesis. 3 Inflammation associated with diet may contribute to pancreatic malignancy through the increased level of inflammatory cytokines (e.g., TNF-a; IL-6, IL-8 and interferon-g), reactive oxygen species and mediators in the inflammatory pathway (e.g., NF-rB and cyclooxygenase-2), leading to increased cell cycling, loss of tumor suppressor function, and stimulated oncogene expression, all of which may induce modifications of key cancer-related proteins and, ultimately, tumorigenesis. 3, 44 Major strengths of our study include its prospective cohort design, which conceptually minimizes the possibility of recall bias, especially disease-differential bias. The long follow-up in the PLCO cohort among a large study population allowed for an in-depth evaluation of effect modification by time from the DHQ to cancer diagnosis. Detailed information on a comprehensive list of covariates allowed for careful adjustment in the analyses. The E-DII, a constructvalidated tool which is literature-based and takes into account the whole diet instead of single nutrients or foods, provided a comprehensive assessment of dietary inflammatory potential. It has major advantages over other a priori dietary patterns as it was developed specifically to reflect diet's effect on inflammation, which plays a central role in pancreatic cancer etiology. In addition, the use of a validated FFQ which covered major foods and nutrients consumed by Americans, and availability of a majority of food parameters that comprise the DII to calculate the E-DII scores helped to create a large contrast of E-DII scores in this study population. Overall, this population had a higher proportion of lower DII scores (i.e., more anti-inflammatory diets) compared to other US cohorts, though the range in DII scores also was wider. 23, [45] [46] [47] This could reflect the tendency of generally healthier, more compliant individuals who are willing to participate in such a study to eat healthier diets. With such a large range of exposure values, our study provided a unique opportunity to observe effects of comparing distinctly contrasting quintiles. 46, 47 The significant divergent associations observed in two distinct follow-up periods and the evidence of inverse association between proinflammatory diet and pancreatic cancer within <4 years of follow up, supported the previous PLCO findings where inverse associations were found between saturated fat intake and pancreatic cancer in the shorter follow-up period, and highlights the need to investigate this finding in other cohorts. 32, 33 There also are limitations worth noting. First, it is likely the case number was not large enough in some stratified analyses to allow sufficient statistical power to observe significant associations. Exclusion criteria resulted in exclusion of over 50,000 subjects, and there was higher proportion of pancreatic cancer cases, higher E-DII scores, as well as greater likelihood of multiple pancreatic risk factors among excluded participants. This may have introduced selection bias and resulted in underestimation of the association. The FFQ is prone to response set bias, including social approval and social desirability, leading to measurement error in FFQ data as another unavoidable limitation, which may have resulted in some misclassification of the E-DII score. 48 Unfortunately, these response sets, which can be controlled analytically, were not measured in the PLCO. Although follow-up data were available on most covariates, the large amount of missing information impeded our ability to use these data. Evaluation of the E-DII at a single time point could result in nondifferential misclassification of exposure given that diet may change over time. However, we previously found DII scores were relatively stable over a long timeframe in postmenopausal women who were of comparable ages as ours. 49 Another limitation of the study is that data were available on only 35 out of the 45 DII components used to calculate the E-DII scores; however, the range of DII scores may rely more on the total amount of inflammatory components actually consumed rather than the number of available DII components. 50 In many populations, omitting even 15-20 parameters has little effect on DII scores. For example, in the SEASONS study, we demonstrated that DII scores based on multiple days of 24-hr recalls, with 44 evaluable food parameters, were very similar to DII scores derived from a 7-day dietary recall (a structured questionnaire similar in appearance to an FFQ), that provided only 27 evaluable food parameters. 24 This probably is due to the fact that nonevaluable items (i.e., those not specifically listed on the FFQ) are not commonly eaten in most populations. While we adjusted for important potential confounders, residual or unmeasured confounding cannot be ruled out. In addition, the finding of a relatively large inverse association in the first 4 years of follow-up (HR 5 0.60) should be interpreted with caution. It is possible that the results were affected by these aforementioned biases.
In conclusion, this study does not support an association between inflammatory potential of diet and pancreatic cancer risk in the PLCO cohort. However, time significantly modified the association. There was evidence of an inverse association between E-DII scores and pancreatic cancer in the first 4 years of follow-up, suggesting dietary changes due to undiagnosed disease (or a precursor condition) might affect appetite and food choices to lower the E-DII scores in the early stage, while a positive association was suggested by a significant trend in the follow-up of 4 years. Future prospective cohort studies assessing dietary factors and pancreatic cancer risk should consider differences in associations by follow-up time. Additional cohort studies with large number of cases are warranted to examine effect modification of E-DII and pancreatic cancer by important lifestyle risk factors.
